rs145477274
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_016219.5(MAN1B1):c.1229G>A(p.Arg410His) variant causes a missense change. The variant allele was found at a frequency of 0.000681 in 1,612,990 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R410C) has been classified as Uncertain significance.
Frequency
Consequence
NM_016219.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAN1B1 | NM_016219.5 | c.1229G>A | p.Arg410His | missense_variant | 8/13 | ENST00000371589.9 | |
LOC124902313 | XR_007061873.1 | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAN1B1 | ENST00000371589.9 | c.1229G>A | p.Arg410His | missense_variant | 8/13 | 1 | NM_016219.5 | P2 |
Frequencies
GnomAD3 genomes ? AF: 0.00114 AC: 174AN: 152250Hom.: 2 Cov.: 34
GnomAD3 exomes AF: 0.00249 AC: 623AN: 250466Hom.: 16 AF XY: 0.00234 AC XY: 317AN XY: 135646
GnomAD4 exome AF: 0.000633 AC: 925AN: 1460622Hom.: 17 Cov.: 33 AF XY: 0.000636 AC XY: 462AN XY: 726502
GnomAD4 genome ? AF: 0.00114 AC: 173AN: 152368Hom.: 2 Cov.: 34 AF XY: 0.00123 AC XY: 92AN XY: 74506
ClinVar
Submissions by phenotype
Rafiq syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Invitae | Dec 31, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 24, 2017 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 24, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at